Loading
A Slovak study comparing the PanTum Detect blood test with PET-CT scans in people with suspected cancer and in healthy people.
PanTumPET (NCT06842615) is a randomised interventional study sponsored by Comenius University. It evaluates the diagnostic performance of the epitope detection in monocytes test PanTum Detect for early detection of pre-malignant or malignant lesions.
The registry record, read on 29 October 2026, gives its status as recruiting, with an estimated 134 participants, a start on 25 May 2025 and primary completion expected on 31 December 2027.
Shares Zyagnum, PanTum Detect, Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Shares Multi-cancer early detection (MCED), Liquid biopsy (ctDNA).
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/